Global Pelvic Floor Diagnostic Testing Market

Pelvic Floor Diagnostic Testing Market size was valued at US$ 3.67 Bn in 2023 and the total revenue is expected to grow at 4.3% through 2024 to 2030, reaching nearly US$ 4.92 Bn.

Pelvic Floor Diagnostic Testing Market Overview:

The Pelvic Floor is a combination of various muscles that are responsible to support the rectum. To initiate bowel movement pelvic floor muscles contract and relax in sync to regulate bowel movement, bladder function, sexual intercourse in women, and urination. Pelvic floor dysfunction occurs due to high tension on the pelvic floor muscles and this leads to various issues such as pain in the back, pelvic region, genital area, constipation, and painful urination. To treat pelvic floor dysfunction various tests are performed and diagnosis is carried out.To know about the Research Methodology :- Request Free Sample Report

Pelvic Floor Diagnostic Testing Market Dynamics:

Expansion of the geriatric population globally, urinary incontinence in pregnant women, and awareness & healthcare programs for treatment options are projected to boost the growth of the pelvic floor diagnostic testing market. In terms of pelvic dysfunction, the pelvic floor diagnostics industry has emerged as a profitable research field. With the growing need for high-resolution pictures, the advancement of imaging technology is gaining traction.

Improved knowledge and awareness of the diagnostic alternatives accessible among the expanding population is fueling demand. Ultrasound systems provide high-resolution imaging that is dependable. The pelvic floor diagnostics market is expected to see a spike in demand as the procedures for detecting, diagnosing, and treating related illnesses evolve and are less invasive. The major countries such as U.S., Canada, India, China, and Japan consistently reflect the high demand for pelvic floor diagnostics services as the countries are leading service providers for pelvic floor diagnostic services.

In the pelvic floor diagnostics market, key companies such as Cooper Surgical Inc., Medtronic Plc., SRS Medical, Stryker's, MEDSPIRA, MEDKONSULT medical technology s.r.o., and EndoMed Systems are concentrating on strategic mergers and acquisitions to unlock market potential. Efficiency in new and specialized product portfolios is driving this. The market is also expected to grow as research and development efforts to detect pelvic floor diseases increase.

In addition, innovations and development in product portfolio by the leading market players is likely to boost the growth of the market in the forecast timeframe. For instance, Neusoft Corporation announced their product line in June 2021, which included the NeuAngio 30F high-speed floor-mounted DSA equipment, as well as medical imaging for diagnostics.

Pelvic Floor Diagnostic Testing Market Segment Analysis:

The ultrasound equipment segment is dominating the Product segment of the Global Pelvic Floor Diagnostic Testing Market:

The demand for ultrasound equipment over radiographic techniques in the pelvic floor diagnostics market is growing internationally. Ultrasound systems had the largest market share of 32.6% in 2023, and are anticipated to grow at a CAGR of 5.3 % over the forecast period. There are three types of ultrasound imaging such as color doppler, power doppler, and spectral doppler. Further benefits offered by the ultrasound equipment such as no incisions, generally painless, no exposure to ionizing radiations, and accuracy in test results are projected to lift the market. A fresh interest in diagnostic imaging in urogynecology and female urology has been sparked by technological improvements in ultrasound systems. Further, growing disposable income and awareness regarding pelvic floor and learning on social media platforms are likely to drive the growth of the market in the forecast period.

The Hospital segment is considered to supplement the growth of the Global Pelvic Floor Diagnostic Testing Market.

In the year 2023, the hospital's segment had the highest market share of 56.6 %, and it is expected to grow at a CAGR of 5.6% over the forecast period. By the end of the forecast period, the hospital segment is expected to generate over US$ 2,039.0 Million in revenue. Improved health infrastructure, a growing number of experienced physicians, the availability of advanced devices, and rising research and development (R&D) spending for medical devices are all contributing to the industry's growth. Further, hospital’s adopting new machineries with technological innovations and advancement are motivating the market growth.

Pelvic Floor Diagnostic Testing Market Regional Insights:

North America is dominating the regional market for pelvic floor diagnostic testing market. The US is leading in the Pelvic floor diagnostic market in the region which is expected to grow steadily over the forecast time frame. According to the study, the US. will have an 83.5 % market share in North America in 2023. The rising prevalence of pelvic floor disorders among pregnant women, as well as the resulting increase in healthcare expenditure, are driving the growth of the pelvic floor diagnostics market in the country. Mexico is likely to gain significant adhesion in the market accounting for 37.9% of market share in 2023. Due to the growing demand for various pelvic floor diagnostic testing services. Further, increasing investment and growing knowledge about the test and services offered by various hospitals and clinics in the regions, increasing population, and government policies are likely to boost the market expansion.

The objective of the report is to present a comprehensive analysis of the Global Pelvic Floor Diagnostic Testing Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the Global Pelvic Floor Diagnostic Testing Market dynamics, structure by analyzing the market segments and project the global market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the global market make the report investor’s guide.

Pelvic Floor Diagnostic Testing Market Scope: Inquire before buying

Pelvic Floor Diagnostic Testing Market Key Players:

1. Angioscore Ltd.
2. Medtronic Inc.
3. St. Jude Medical
4. C.R.Bard
5. Bayer,
6. Endologix
7. Volcano Corporation
8. Edward Lifesciences
9. Endologix
10. Abbott Laboratories
11. B Braun Inc.
12. Cook Group Inc.
13. Covidien
14. Volcano Corporation
15. Cordis Corporation
16. Boston Scientific Corporation
17. Teleflex Medical
18. Terumo Interventional Systems Inc.
19. Laborie, Inc.,
20. Cooper Surgical Inc.
21. SRS Medical
22. Stryker’
23. MEDSPIRA
24. MEDKONSULT medical technology s.r.o.
25. Endo Med Systems
26. Richard Wolf
27. Schölly Fiberoptic
28. Zhuhai Seesheen Medical Technology
29. KARL STORZ
30. Cadwell
31. The Prometheus Group
32. Neurosoft
33. Noraxon USA.

FAQs:

1. What is the global market value in 2023?
Ans: Global Pelvic Floor Diagnostic Testing market value in 2023 was estimated as 3.67 Billion USD.

2. What is the global Pelvic Floor Diagnostic Testing market growth?
Ans: The global Pelvic Floor Diagnostic Testing market is anticipated to grow with a CAGR of 4.3% in the forecast period and is likely to reach USD 4.92 Billion by the end of 2030.

3. Which End-User segment is expected to dominate the global market during the forecast period?
Ans: The hospital's segment had the highest market share of 56.6 %, and it is expected to grow at a CAGR of 5.6% over the forecast period. By the end of the forecast period, the hospital segment is expected to generate over US$ 2,039.0 Million in revenue.

4. Who are the key players in the Pelvic Floor Diagnostic Testing market?
Ans: Some key players operating in the Pelvic Floor Diagnostic Testing market include Laborie, Inc., Cooper Surgical Inc., Medtronic Plc., SRS Medical, Stryker’s, MEDSPIRA, MEDKONSULT medical technology s.r.o., EndoMed Systems, Richard Wolf, Schölly Fiberoptic.

5. What is the key driving factor for the growth of the global Pelvic Floor Diagnostic Testing market?
Ans: Key factors that are driving the Pelvic Floor Diagnostic Testing market growth include rising healthcare spending and favorable reimbursement policies that will encourage research initiatives in the market, enabling growth over the forecast period.